Ad Scientiam Launches International Study to Assess Disability Progression in Multiple Sclerosis With MSCopilot

Contributed by: ACCESS Newswire

Logo

Tags

Ad Scientiam

Healthcare & Pharmaceutical

Partnerships

More Like This

All Digital Mobility Outcomes developed by the Mobilise-D consortium will be accessible through the Empatica Health Monitoring Platform (Photo: Business Wire)

Empatica Announces Integration of Mobilise-D Mobility Outcomes, Advancing Toward Unified Solution for Clinical Professionals

PR Newswire associated0

medac cooperates with Scienta Lab to generate new insights in rheumatology care with AI-powered solutions

Tiziana Life Sciences Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program

SciBase Announces Positive Findings in Case Study Monitoring Treatment Outcomes in Atopic Dermatitis Patient

Tiziana Life Sciences Announces Positive Six-Month Clinical Results in Multiple Sclerosis Patients Treated with Intranasal Foralumab

Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers

Exscientia Initiates Clinical Study to Further Evaluate Functional Precision Medicine Platform in Cancer Patients

OPPSCIENCE & ANFSI partner together to fight crime (Photo: Business Wire)

The ANFSI and OPPSCIENCE are Working Together to Adapt Methods of Investigation in Response to New Digital Challenges by Integrating the SPECTRA Intelligence Analysis Management Software